Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens
- PMID: 9179972
Pathologic prognostic parameters in bladder urothelial biopsy, transurethral resection, and cystectomy specimens
Abstract
Pathologists play an important role not only in diagnosing bladder tumors but also in reporting features important in determining prognosis. In this article, the authors review histopathologic features that may help determine prognosis including depth of invasion, grade of tumor, multicentricity, tumor size, and presence of (1) carcinoma in situ, (2) variant histological patterns, and (3) lymphatic and vascular invasion. The biology of bladder tumors is being extensively studied, and newer prognostic factors based on these molecular studies are emerging, some of which appear to show prognostic significance in limited clinical reports. Such factors as blood group antigen expression, proliferative indices, molecular markers, and new proposed techniques are discussed.
Similar articles
-
Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy.J Urol. 2003 Mar;169(3):955-60. doi: 10.1097/01.ju.0000043639.55877.17. J Urol. 2003. PMID: 12576821
-
Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.Scand J Urol Nephrol. 2004;38(3):231-5. doi: 10.1080/00365590410029141. Scand J Urol Nephrol. 2004. PMID: 15204377
-
A practical approach to bladder sampling and diagnostic reporting of pathological findings.Pathologica. 2001 Dec;93(6):688-92. Pathologica. 2001. PMID: 11785124 Review.
-
Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.J Urol. 2008 Nov;180(5):1928-32; discussion 1932. doi: 10.1016/j.juro.2008.07.056. Epub 2008 Sep 17. J Urol. 2008. PMID: 18801529
-
Urothelial carcinoma in the prostatic urethra and prostate: current controversies.Expert Rev Anticancer Ther. 2007 Mar;7(3):383-90. doi: 10.1586/14737140.7.3.383. Expert Rev Anticancer Ther. 2007. PMID: 17338657 Review.
Cited by
-
Update on the management of non-muscle invasive bladder cancer.Can Urol Assoc J. 2010 Feb;4(1):56-64. doi: 10.5489/cuaj.777. Can Urol Assoc J. 2010. PMID: 20165581 Free PMC article.
-
A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens.BJU Int. 2019 Jan;123(1):11-21. doi: 10.1111/bju.14417. Epub 2018 Jun 29. BJU Int. 2019. PMID: 29807387 Free PMC article.
-
Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history.Rev Urol. 2008 Winter;10(1):31-43. Rev Urol. 2008. PMID: 18470273 Free PMC article.
-
The effect of tumor invasion patterns on pathologic stage of bladder urothelial carcinomas.Pathol Oncol Res. 2005;11(2):87-91. doi: 10.1007/BF02893372. Epub 2005 Jul 1. Pathol Oncol Res. 2005. PMID: 15999152
-
Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection.Onco Targets Ther. 2015 Nov 18;8:3401-6. doi: 10.2147/OTT.S95609. eCollection 2015. Onco Targets Ther. 2015. PMID: 26604797 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical